CTOs on the Move

Market Drugs Medical

www.marketdrugsmedical.com

 
Market Drugs Medical is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Maverick Therapeutics

Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Mavericks highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.

Alpha Lion

Inspiring SuperHumans All Over The World to Achieve Their Dream Physique and Dream Lifestyle.

Ra Medical

Advanced Excimer Laser-Based Vascular and Dermatological Therapies We are a medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. We believe our products enhance patients` quality of life by restoring blood-flow in arteries and clearing chronic skin conditions. We currently manufacture and market two lines of products: DABRA Catheter and Laser is cleared by the U.S. FDA as a tool for the minimally invasive endovascular treatment of vascular blockages resulting from lower extremity vascular disease, including peripheral artery disease (PAD) and critical limb ischemia (CLI). Pharos Excimer Laser is FDA cleared as a tool used in the treatment of inflammatory skin conditions, including psoriasis, atopic dermatitis, and leukoderma.

Cambridge Healthtech Institute

Cambridge Healthtech Institute is a Needham Heights, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cloudbreak Health

Cloudbreak is a language access and telehealth company that has been around for over 16 years. In the course of building out the technology powering our Martti video remote interpretation solution, we developed unparalleled understanding of networks, video traffic, and the technology to enable them.